about
Molecular Evidence of Oysters as Vehicle of Norovirus GII.P17-GII.17Rotavirus vaccines: targeting the developing world.Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data.A universal primer-independent next-generation sequencing approach for investigations of norovirus outbreaks and novel variants.Characterization of rotavirus strains in a Danish population: high frequency of mixed infections and diversity within the VP4 gene of P[8] strains.Point-of-use water treatment and use among mothers in Malawi.The application of new molecular methods in the investigation of a waterborne outbreak of norovirus in Denmark, 2012.Reduced price on rotavirus vaccines: enough to facilitate access where most needed?Rotavirus typing methods and algorithms.The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial.Rotavirus vaccines: current prospects and future challenges.Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003.Bottle-feeding and the Risk of Pyloric Stenosis.Rotavirus particles can survive storage in ambient tropical temperatures for more than 2 months.Epidemiological studies of rotavirus infection in Guinea-Bissau, West Africa.Sequence analysis of the capsid gene during a genotype II.4 dominated norovirus season in one university hospital: identification of possible transmission routesCohort study of Guinean children: incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during the first 2 years of life.Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children.Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs.Human parechovirus infection, DenmarkIncidence and cost of rotavirus hospitalizations in DenmarkDevelopment of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.Rotavirus disease in Guinea-Bissau, West Africa: a review of longitudinal community and hospital studies.Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.Global emergence of enterovirus D68: a systematic review.Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors.Evaluation of the enterovirus laboratory surveillance system in Denmark, 2010 to 2013.Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment.Severe Human Parechovirus Infections in Infants and the Role of Older Siblings.Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial.Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.Co-circulation of multiple subtypes of enterovirus A71 (EV- A71) genotype C, including novel recombinants characterised by use of whole genome sequencing (WGS), Denmark 2016.[A historical perspective of Ebola virus].An enhanced Enterovirus surveillance system allows identification and characterization of rare and emerging respiratory enteroviruses in Denmark, 2015-16.Phylogenetic and epidemiological analysis of measles outbreaks in Denmark, 2013 to 2014.Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003.Rotavirus vaccines: past, present, and future.Hospital surveillance of rotavirus infection and nosocomial transmission of rotavirus disease among children in Guinea-Bissau.Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection.Molecular epidemiology and the evolution of human coxsackievirus A6.
P50
Q28112094-7270C87A-D4C4-4511-A75C-34E5612B3AE2Q30795376-180442AC-5AEC-461F-8632-DECDF82FE0BCQ31108130-1667370B-018B-4221-93DF-73470A7132E7Q33678188-22BC1F46-9A49-4022-94F5-155654F57B26Q33753031-D77F0761-6710-4CA6-B7DB-D4DF40CE1135Q33883981-DE0B9A6C-D233-48A2-9352-EF306CEC0C83Q34182704-C7D50265-4065-4128-A620-4F81ABEC21CCQ34288836-ECCF143F-5B0F-4084-88F3-937CE94840F0Q34306568-CF25C6E0-11C1-4BD3-B16A-3869A374EB17Q34482008-85763FEE-EE78-4F7B-8CBF-C4926D81A916Q34550164-89B5F394-33A9-4193-8AB2-21103A3FB07CQ34577584-AE6241A5-1068-4102-A835-40E7FFE49A89Q34642097-B6E9D4F2-6D82-4579-8228-F7734C6AE58FQ34988535-DB264D86-394F-4546-8AAF-0023F0483A3FQ35156796-AD5C60AA-376C-4D5D-B93A-097D74E8F5BDQ35543160-44321FF2-0B7C-4A9B-9B2B-A355BDE921EFQ35922383-05D41878-A9FC-4916-9E7A-3AA3D28A6D78Q35970302-A1898B7F-1466-49BF-BD67-1CB7945D0A7AQ36223147-92FFAC7C-7E3E-4699-A92E-9A516A197221Q37449038-CFEFBA5A-8596-4465-9F9B-C89485402E5BQ37473747-762BE30E-F01C-409D-9FDC-0F5FB2034A49Q37660937-862CFEEF-2838-48A8-87ED-5CDCF216D4F1Q37777741-6CC4945B-ED05-4A92-8C9C-B39F2F331A5AQ38070799-EA6A8100-10D0-431A-905A-2669CB27EA42Q38756005-5B8A050C-8B12-4554-B885-764268F73E54Q39625935-66505270-8125-485F-BCF2-7AF78B0C826AQ39770868-AD371475-2D1E-41D9-A099-263246AB5BE8Q39833076-B8CA0043-1556-4911-9F7C-7457F520B356Q39927498-C3E3EE0B-0775-4749-8150-C0B8F807EB61Q40125516-BE0250B3-34BC-4D91-97C9-5162112577B4Q40127199-FDB07E15-3A25-433D-8677-079B3A091E7AQ40133392-4AA73E85-2890-46C6-B95F-51282CC7D031Q40137213-47EB339E-0B39-42C8-AF45-C107A86424ABQ40158680-ACA1F925-96BB-46E5-B0ED-B27318DE440CQ40356060-FFA21120-16E4-47A4-BAC4-CD5637E29772Q40398497-1B536EB1-FC01-4357-8967-9CA9F98AB650Q40421265-870EB93E-F5BD-4AC3-BA12-32854CD52D14Q40450661-314F9FB5-137D-4139-A912-7A8A2A3A3E06Q40523302-6BB8729E-3DBB-46A7-9E26-3EE04E7651BBQ40558568-0C631745-42BA-46FC-8F6B-E3B100EABB3E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thea K. Fischer
@ast
Thea K. Fischer
@en
Thea K. Fischer
@es
Thea K. Fischer
@nl
Thea K. Fischer
@sl
type
label
Thea K. Fischer
@ast
Thea K. Fischer
@en
Thea K. Fischer
@es
Thea K. Fischer
@nl
Thea K. Fischer
@sl
prefLabel
Thea K. Fischer
@ast
Thea K. Fischer
@en
Thea K. Fischer
@es
Thea K. Fischer
@nl
Thea K. Fischer
@sl
P1053
L-8254-2013
P106
P1153
7402050966
P21
P2798
P31
P3829
P496
0000-0003-4812-980X